Heena Mistry

Heena Mistry

University of Southampton

H-index: 8

Europe-United Kingdom

About Heena Mistry

Heena Mistry, With an exceptional h-index of 8 and a recent h-index of 8 (since 2020), a distinguished researcher at University of Southampton, specializes in the field of Difficult Asthma, Severe Asthma, Epigenetics of Asthma.

His recent articles reflect a diverse array of research interests and contributions to the field:

Associations of Breathing Pattern Disorder and Nijmegen Score With Clinical Outcomes in Difficult-to-Treat Asthma

Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

How Does Mild Asthma Differ Phenotypically from Difficult-to-Treat Asthma?

Cytotoxic CD4+ tissue-resident memory T cells are associated with asthma severity

The detrimental clinical associations of anxiety and depression with difficult asthma outcomes

Phenotypes and Clinical Outcomes of Omalizumab and Mepolizumab treated Difficult Asthma patients

COVID-19: Rapid antigen detection for SARS-CoV-2 by lateral flow assay: A national systematic evaluation of sensitivity and specificity for mass-testing

Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Heena Mistry Information

University

Position

Respiratory Clinical Research Fellow

Citations(all)

1559

Citations(since 2020)

1551

Cited By

23

hIndex(all)

8

hIndex(since 2020)

8

i10Index(all)

8

i10Index(since 2020)

8

Email

University Profile Page

Google Scholar

Heena Mistry Skills & Research Interests

Difficult Asthma

Severe Asthma

Epigenetics of Asthma

Top articles of Heena Mistry

Associations of Breathing Pattern Disorder and Nijmegen Score With Clinical Outcomes in Difficult-to-Treat Asthma

The Journal of Allergy and Clinical Immunology: In Practice

2024/4/1

Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Nature Communications

2024/1/31

How Does Mild Asthma Differ Phenotypically from Difficult-to-Treat Asthma?

Journal of Asthma and Allergy

2023/12/31

Cytotoxic CD4+ tissue-resident memory T cells are associated with asthma severity

Med

2023/12/8

The detrimental clinical associations of anxiety and depression with difficult asthma outcomes

Journal of Personalized Medicine

2022/4/26

Phenotypes and Clinical Outcomes of Omalizumab and Mepolizumab treated Difficult Asthma patients

Authorea Preprints

2022/3/30

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Lancet (London, England)

2021/2/13

The clinical implications of Aspergillus fumigatus sensitization in difficult-to-treat asthma patients

The Journal of Allergy and Clinical Immunology: In Practice

2021/12/1

New Real-World Insights Into Severe Asthma: All About the Eosinophil?

Chest

2021/9/1

Heena Mistry
Heena Mistry

H-Index: 3

Real‐world omalizumab and mepolizumab treated difficult asthma phenotypes and their clinical outcomes

Clinical & Experimental Allergy

2021/8

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Medrxiv

2021/6/16

New perspectives on difficult asthma; sex and age of asthma-onset based phenotypes

The Journal of Allergy and Clinical Immunology: In Practice

2020/11/1

See List of Professors in Heena Mistry University(University of Southampton)